South Denver Cardiology Associates

Littleton, Colorado 80124

6 studies enrolling now · 18 studies all time

What they study most

AV Block, Acute Coronary Syndrome (ACS), Atrial Fibrillation, Cardiovascular Disease, Coronary Heart Disease (CHD), Cryptogenic Stroke, Heart Failure, Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure With Preserved Ejection Fraction, Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Reduced Ejection Fraction

Studies at this site

• OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
• GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study — Recruiting now
• The CONFORM Pivotal Trial — Recruiting now
• Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Recruiting now
• Left vs Left Randomized Clinical Trial — Recruiting now
• A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF — Enrolling by invitation
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion — Running, not enrolling
• Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial — Completed
• REDUCE LAP-HF TRIAL II — Running, not enrolling
• A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) — Completed
• Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation — Completed
• Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm — Completed
• A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension — Stopped early
• AMPLATZER Cardiac Plug Clinical Trial — Completed
• Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial — Completed
• Safety Study of Apixaban in Recent Acute Coronary Syndrome — Completed